Back
Status filter :


RESET SEARCH AND FILTERS
Malignant disease
Malignant disease / Antibody responsive malignancy
  atezolizumab Restricted NICE TA525
NICE TA739
NICE TA520
NICE TA584
NICE TA705
NICE TA823
NICE TA638
NICE TA639
NICE TA666
  Solution for infusion
Tecentriq (Roche Products Ltd) Restricted
  avelumab Restricted NICE TA517
NICE TA691
NICE TA645
NICE TA788
  Solution for infusion
Bavencio (Merck Serono Ltd) Restricted
  bevacizumab Restricted NICE TA118
NICE TA212
NICE TA242
NICE TA178
NICE TA214
NICE TA263
NICE TA284
NICE TA285
NICE TA666
NICE TA693
  Solution for infusion
Avastin (Roche Products Ltd) Restricted
  blinatumomab Restricted NICE TA450
NICE TA589
  Powder for solution for infusion
Blincyto (Amgen Ltd) Restricted
  brentuximab vedotin Restricted NICE TA478
NICE TA641
NICE TA524
NICE TA577
  Powder for solution for infusion
Adcetris (Takeda UK Ltd) Restricted
  cemiplimab Restricted NICE TA802
  cetuximab Restricted NICE TA145
NICE TA473
NICE TA242
NICE TA439
NICE TA668
  Solution for infusion
Erbitux (Merck Serono Ltd) Restricted
  daratumumab Restricted NICE TA573
NICE TA763
NICE TA783
  Solution for injection
Darzalex (Janssen-Cilag Ltd) Restricted
  Solution for infusion
Darzalex (Janssen-Cilag Ltd) Restricted
  dinutuximab beta Named Patient Only NICE TA538
  Solution for infusion
Qarziba (EUSA Pharma (UK) Ltd) Named Patient Only
  dostarlimab Restricted NICE TA779
  Solution for infusion
Dostarlimab (Non-proprietary) Restricted
  durvalumab Restricted NICE TA798
  Solution for infusion
Imfinzi (AstraZeneca UK Ltd) Restricted
  gemtuzumab ozogamicin Restricted NICE TA545
  Powder for solution for infusion
Mylotarg (Pfizer Ltd) Restricted
  inotuzumab ozogamicin Restricted NICE TA541
  Powder for solution for infusion
Besponsa (Pfizer Ltd) Restricted
  ipilimumab Restricted NICE TA268
NICE TA319
NICE TA400
NICE TA716
NICE TA724
NICE TA780
NICE TA818
  Solution for infusion
Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  isatuximab Restricted NICE TA658
  mogamulizumab Named Patient Only NICE TA754
NICE TA754
  Solution for infusion
Poteligeo (Kyowa Kirin Ltd) Named Patient Only
  nivolumab Restricted NICE TA384
NICE TA400
NICE TA684
NICE TA417
NICE TA780
NICE TA462
NICE TA655
NICE TA713
NICE TA724
NICE TA530
NICE TA817
NICE TA707
NICE TA746
NICE TA716
NICE TA736
NICE TA818
  Solution for infusion
Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  obinutuzumab Restricted NICE TA343
NICE TA513
NICE TA629
  Solution for infusion
Gazyvaro (Roche Products Ltd) Restricted
  panitumumab Named Patient Only NICE TA242
NICE TA439
  Solution for infusion
Vectibix (Amgen Ltd) Named Patient Only
  pembrolizumab Restricted NICE TA357
NICE TA366
NICE TA766
NICE TA428
NICE TA531
NICE TA683
NICE TA770
NICE TA692
NICE TA540
NICE TA540
NICE TA772
NICE TA650
NICE TA661
NICE TA709
NICE TA737
NICE TA801
  Solution for infusion
Keytruda (Merck Sharp & Dohme (UK) Ltd) Restricted
  pertuzumab Restricted NICE TA424
NICE TA509
NICE TA569
  Solution for infusion
Perjeta (Roche Products Ltd) Restricted
  pertuzumab with trastuzumab Restricted
  Solution for injection
Phesgo (Roche Products Ltd) Restricted
  polatuzumab vedotin Restricted NICE TA649
  rituximab Restricted NICE TA308
NICE TA195
NICE TA243
NICE TA137
NICE TA193
NICE TA226
NICE TA174
NICE TA359
NICE TA561
  Solution for injection
MabThera (Roche Products Ltd) Named Patient Only
  Solution for infusion
MabThera (Roche Products Ltd) Named Patient Only
Rixathon (Sandoz Ltd) Restricted
  sacituzumab govitecan Named Patient Only NICE TA819
  Powder for solution for infusion
Trodelvy (Gilead Sciences Ltd) Named Patient Only
  trastuzumab Restricted NICE TA34
NICE TA257
NICE TA509
NICE TA208
  Solution for injection
Herceptin (Roche Products Ltd) Named Patient Only
  Powder for solution for infusion
Herceptin (Roche Products Ltd) Named Patient Only
Ontruzant (Organon Pharma (UK) Ltd) Restricted
  trastuzumab deruxtecan Restricted NICE TA704
  Powder for solution for infusion
Enhertu (Daiichi Sankyo UK Ltd) Restricted
  trastuzumab emtansine Restricted NICE TA458
NICE TA632
  Powder for solution for infusion
Kadcyla (Roche Products Ltd) Restricted
Malignant disease / Immunotherapy responsive malignancy
  Bacillus Calmette-Guérin On Formulary
  Powder for reconstitution for instillation
OncoTICE (Merck Sharp & Dohme (UK) Ltd) On Formulary
  lenalidomide Restricted NICE TA322
NICE TA171
NICE TA505
NICE TA586
NICE TA587
NICE TA627
NICE TA680
  Capsule
Revlimid (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  mifamurtide Restricted NICE TA235
  pomalidomide Restricted NICE TA427
  Capsule
Imnovid (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  talimogene laherparepvec Restricted NICE TA410
  Solution for injection
Imlygic (Amgen Ltd) Restricted
  thalidomide Restricted NICE TA228
  Capsule
Thalidomide (Non-proprietary) Restricted
Malignant disease / Targeted therapy responsive malignancy
  abemaciclib Restricted NICE TA563
NICE TA725
NICE TA810
  Tablet
Verzenios (Eli Lilly and Company Ltd) Restricted
  acalabrutinib Restricted NICE TA689
NICE TA689
  Capsule
Calquence (AstraZeneca UK Ltd) Restricted
  afatinib Restricted NICE TA310
  Tablet
Giotrif (Boehringer Ingelheim Ltd) Restricted
  alectinib Restricted NICE TA536
  Capsule
Alecensa (Roche Products Ltd) Restricted
  alpelisib Named Patient Only NICE TA816
  Tablet
Piqray (Novartis Pharmaceuticals UK Ltd) Named Patient Only
  asciminib Named Patient Only NICE TA813
  Tablet
Asciminib (Non-proprietary) Named Patient Only
  axitinib Restricted NICE TA333
NICE TA645
NICE TA650
  Tablet
Inlyta (Pfizer Ltd) Restricted
  binimetinib Restricted NICE TA562
  Tablet
Mektovi (Pierre Fabre Ltd) Restricted
  bortezomib Restricted NICE TA370
NICE TA311
NICE TA228
NICE TA129
  Solution for injection
Bortezomib (Non-proprietary) Restricted
  Powder for solution for injection
Bortezomib (Non-proprietary) Restricted
Velcade (Janssen-Cilag Ltd) Restricted
  bosutinib Restricted NICE TA401
  Tablet
Bosulif (Pfizer Ltd) Restricted
  brigatinib Restricted NICE TA571
NICE TA670
  Tablet
Alunbrig (Takeda UK Ltd) Restricted
  Form unstated
Alunbrig (Takeda UK Ltd) Restricted
  cabozantinib Restricted NICE TA463
NICE TA542
NICE TA516
  Tablet
Cabometyx (Ipsen Ltd) Restricted
  Capsule
Cometriq (Ipsen Ltd) Restricted
  Form unstated
Cometriq (Ipsen Ltd) Restricted
  carfilzomib Restricted NICE TA657
NICE TA695
  ceritinib Restricted NICE TA395
NICE TA500
  crizotinib Restricted NICE TA406
NICE TA422
NICE TA529
  Capsule
Xalkori (Pfizer Ltd) Restricted
  dabrafenib Restricted NICE TA321
NICE TA396
NICE TA544
  Capsule
Tafinlar (Novartis Pharmaceuticals UK Ltd) Restricted
  dacomitinib Restricted NICE TA595
  dasatinib Restricted NICE TA426
NICE TA425
  Tablet
Dasatinib (Non-proprietary) Restricted
Sprycel (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  encorafenib Restricted NICE TA562
NICE TA668
  Capsule
Braftovi (Pierre Fabre Ltd) Restricted
  entrectinib Restricted NICE TA643
NICE TA644
  Capsule
Rozlytrek (Roche Products Ltd) Restricted
  erlotinib Restricted NICE TA227
NICE TA258
NICE TA374
NICE TA374
  Tablet
Tarceva (Roche Products Ltd) Restricted
  everolimus Restricted NICE TA421
NICE TA432
NICE TA449
Afinitor® NICE TA498
Certican® NICE TA348
Certican® NICE TA481
  Tablet
Everolimus (Non-proprietary) Restricted
Afinitor (Novartis Pharmaceuticals UK Ltd) Restricted
  fedratinib Restricted NICE TA756
  Capsule
Inrebic (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  gefitinib Restricted NICE TA192
NICE TA374
  Tablet
Iressa (AstraZeneca UK Ltd) Restricted
  gilteritinib Restricted NICE TA642
  ibrutinib Restricted NICE TA429
NICE TA502
NICE TA795
  idelalisib Restricted NICE TA359
NICE TA604
  Tablet
Zydelig (Gilead Sciences Ltd) Restricted
  imatinib Restricted NICE TA326
NICE TA70
NICE TA86
NICE TA209
NICE TA426
NICE TA425
  Tablet
Imatinib (Non-proprietary) Restricted
  ixazomib Restricted NICE TA505
  Capsule
Ninlaro (Takeda UK Ltd) Restricted
  larotrectinib Restricted NICE TA630
  lenvatinib Restricted NICE TA535
NICE TA551
Kisplyx® NICE TA498
  Capsule
Kisplyx (Eisai Ltd) Restricted
Lenvima (Eisai Ltd) Restricted
  lorlatinib Restricted NICE TA628
  midostaurin Restricted NICE TA523
NICE TA728
  Capsule
Rydapt (Novartis Pharmaceuticals UK Ltd) Restricted
  neratinib Restricted NICE TA612
  nilotinib Restricted NICE TA426
NICE TA425
  Capsule
Tasigna (Novartis Pharmaceuticals UK Ltd) Restricted
  nintedanib Restricted NICE TA347
NICE TA379
NICE TA747
  Capsule
Vargatef (Boehringer Ingelheim Ltd) Restricted
  niraparib Restricted NICE TA673
NICE TA784
  Capsule
Zejula (GlaxoSmithKline UK Ltd) Restricted
  olaparib Restricted NICE TA598
NICE TA620
NICE TA693
NICE TA831
  Tablet
Lynparza (AstraZeneca UK Ltd) Restricted
  osimertinib Restricted NICE TA653
NICE TA654
NICE TA761
  Tablet
Tagrisso (AstraZeneca UK Ltd) Restricted
  palbociclib Restricted NICE TA495
NICE TA619
  pazopanib Restricted NICE TA215
  Tablet
Votrient (Novartis Pharmaceuticals UK Ltd) Restricted
  pemigatinib Named Patient Only NICE TA722
  Tablet
Pemazyre (Incyte Biosciences UK Ltd) Named Patient Only
  ponatinib Restricted NICE TA451
  Tablet
Iclusig (Incyte Biosciences UK Ltd) Restricted
  regorafenib Restricted NICE TA488
NICE TA555
  Tablet
Stivarga (Bayer Plc) Restricted
  ribociclib Restricted NICE TA496
NICE TA687
  Tablet
Kisqali (Novartis Pharmaceuticals UK Ltd) Restricted
  rucaparib Restricted NICE TA611
  Tablet
Rubraca (Clovis Oncology UK Ltd) Restricted
  ruxolitinib Restricted NICE TA386
  Tablet
Jakavi (Novartis Pharmaceuticals UK Ltd) Restricted
  selpercatinib Restricted NICE TA742
NICE TA760
  Capsule
Retsevmo (Eli Lilly and Company Ltd) Restricted
  sorafenib Restricted NICE TA178
NICE TA474
NICE TA535
  Tablet
Nexavar (Bayer Plc) Restricted
  sotorasib Restricted NICE TA781
  Tablet
Lumykras (Amgen Ltd) Restricted
  sunitinib Restricted NICE TA169
NICE TA179
NICE TA178
NICE TA449
  Capsule
Sutent (Pfizer Ltd) Restricted
  tepotinib Named Patient Only NICE TA789
  Tablet
Tepmetko (Merck Serono Ltd) Named Patient Only
  tivozanib Restricted NICE TA512
  Capsule
Fotivda (EUSA Pharma (UK) Ltd) Restricted
  trametinib Restricted NICE TA396
NICE TA544
  Tablet
Mekinist (Novartis Pharmaceuticals UK Ltd) Restricted
  tucatinib Named Patient Only NICE TA786
  Tablet
Tukysa (Seagen U.K. Ltd) Named Patient Only
  vemurafenib Restricted NICE TA269
  Tablet
Zelboraf (Roche Products Ltd) Restricted
  venetoclax Restricted NICE TA561
NICE TA663
NICE TA796
NICE TA765
NICE TA787
  Tablet
Venclyxto (AbbVie Ltd) Restricted
Malignant disease / Cytotoxic responsive malignancy
  arsenic trioxide Restricted NICE TA526
  Solution for infusion
Trisenox (Teva UK Ltd) Restricted
  azacitidine Restricted NICE TA399
NICE TA218
  Powder for suspension for injection
Azacitidine (Non-proprietary) Restricted
Vidaza (Bristol-Myers Squibb Pharmaceuticals Ltd) Restricted
  bendamustine hydrochloride Restricted NICE TA216
NICE TA472
  Powder for solution for infusion
Bendamustine hydrochloride (Non-proprietary) Restricted
  bleomycin On Formulary
  busulfan On Formulary
  Tablet
Busulfan (Non-proprietary) On Formulary
  cabazitaxel Restricted NICE TA391
  Solution for infusion
Jevtana (Sanofi Genzyme) Restricted
  capecitabine Restricted NICE TA263
NICE TA212
NICE TA191
NICE TA61
NICE TA100
  Tablet
Capecitabine (Non-proprietary) Restricted
  carboplatin On Formulary NICE TA284
NICE TA285
  Solution for infusion
Carboplatin (Non-proprietary) On Formulary
  carmustine On Formulary NICE TA121
  chlorambucil On Formulary NICE TA343
NICE TA344
  Tablet
Chlorambucil (Non-proprietary) On Formulary
  chlormethine Named Patient Only NICE TA720
  Gel
Ledaga (Recordati Rare Diseases UK Ltd) Named Patient Only
  cisplatin On Formulary
  Solution for infusion
Cisplatin (Non-proprietary) On Formulary
  cladribine On Formulary NICE TA616
  Solution for injection
Litak (Lipomed GmbH) On Formulary
  Solution for infusion
Leustat (Atnahs Pharma UK Ltd) On Formulary
  cyclophosphamide On Formulary
  Tablet
Cyclophosphamide (Non-proprietary) On Formulary
  Powder for solution for injection
Cyclophosphamide (Non-proprietary) On Formulary
  cytarabine On Formulary
  Solution for injection
Cytarabine (Non-proprietary) On Formulary
  dacarbazine On Formulary
  Powder for solution for injection
Dacarbazine (Non-proprietary) On Formulary
  daunorubicin On Formulary
  daunorubicin with cytarabine Restricted NICE TA552
  Powder for solution for infusion
Vyxeos (Jazz Pharmaceuticals UK Ltd) Restricted
  docetaxel Restricted NICE TA101
NICE TA509
  Solution for infusion
Docetaxel (Non-proprietary) Restricted
  doxorubicin hydrochloride On Formulary NICE TA389
NICE TA465
  Solution for injection
Doxorubicin hydrochloride (Non-proprietary) On Formulary
  Solution for infusion
Caelyx (Baxter Healthcare Ltd) On Formulary
  epirubicin hydrochloride On Formulary
  Solution for injection
Epirubicin hydrochloride (Non-proprietary) On Formulary
  eribulin Restricted NICE TA423
NICE TA515
  Solution for injection
Halaven (Eisai Ltd) Restricted
  etoposide On Formulary
  Capsule
Vepesid (Neon Healthcare Ltd) On Formulary
  Solution for infusion
Etoposide (Non-proprietary) On Formulary
  fludarabine phosphate On Formulary NICE TA119
NICE TA29
  Tablet
Fludara (Sanofi) On Formulary
  Solution for injection
Fludarabine phosphate (Non-proprietary) On Formulary
  Powder for solution for injection
Fludarabine phosphate (Non-proprietary) On Formulary
  fluorouracil On Formulary
  Solution for injection
Fluorouracil (Non-proprietary) On Formulary
  Solution for infusion
Fluorouracil (Non-proprietary) On Formulary
  Cream
Efudix (Viatris UK Healthcare Ltd) On Formulary
  gemcitabine Restricted NICE TA25
NICE TA116
NICE TA285
NICE TA389
NICE TA476
  Solution for infusion
Gemcitabine (Non-proprietary) Restricted
  hydroxycarbamide Shared Care
  Capsule
Hydroxycarbamide (Non-proprietary) Shared Care
Hydrea (Neon Healthcare Ltd) Shared Care
  idarubicin hydrochloride Named Patient Only
  Capsule
Zavedos (Pfizer Ltd) Named Patient Only
  Powder for solution for injection
Zavedos (Pfizer Ltd) Named Patient Only
  ifosfamide On Formulary
  Powder for solution for injection
Ifosfamide (Non-proprietary) On Formulary
  irinotecan hydrochloride Restricted NICE TA440
  Solution for infusion
Irinotecan hydrochloride (Non-proprietary) Restricted
Campto (Pfizer Ltd) Restricted
  lomustine On Formulary
  Capsule
Lomustine (Non-proprietary) On Formulary
  melphalan On Formulary
  Tablet
Melphalan (Non-proprietary) On Formulary
  Powder and solvent for solution for injection
Melphalan (Non-proprietary) On Formulary
  mercaptopurine On Formulary
  Tablet
Mercaptopurine (Non-proprietary) On Formulary
  methotrexate On Formulary
  Tablet
Methotrexate (Non-proprietary) On Formulary
  Oral solution
Methotrexate (Non-proprietary) On Formulary
  Solution for infusion
Methotrexate (Non-proprietary) On Formulary
  mitomycin On Formulary
  Powder for solution for injection
Mitomycin (Non-proprietary) On Formulary
  mitoxantrone On Formulary
  Solution for infusion
Mitoxantrone (Non-proprietary) On Formulary
  oxaliplatin Restricted NICE TA100
NICE TA93
  Solution for infusion
Oxaliplatin (Non-proprietary) Restricted
  paclitaxel Restricted NICE TA55
NICE TA284
NICE TA389
NICE TA476
  Solution for infusion
Paclitaxel (Non-proprietary) Restricted
  panobinostat Restricted NICE TA380
  Capsule
Farydak (Secura Bio (Ireland) Ltd) Restricted
  pegaspargase Named Patient Only NICE TA408
  pemetrexed Restricted NICE TA124
NICE TA181
NICE TA402
NICE TA190
NICE TA135
  pentostatin On Formulary
  Powder for solution for injection
Nipent (Pfizer Ltd) On Formulary
  pixantrone Restricted NICE TA306
  procarbazine On Formulary
  Capsule
Procarbazine (Non-proprietary) On Formulary
  temozolomide Restricted NICE TA23
NICE TA121
  Capsule
Temozolomide (Non-proprietary) Restricted
Temodal (Merck Sharp & Dohme (UK) Ltd) Restricted
  topotecan Restricted NICE TA183
NICE TA184
NICE TA389
  Capsule
Hycamtin (Novartis Pharmaceuticals UK Ltd) Restricted
  Solution for infusion
Topotecan (Non-proprietary) Restricted
  trabectedin Restricted NICE TA185
NICE TA389
  treosulfan On Formulary NICE TA640
  Capsule
Treosulfan (Non-proprietary) On Formulary
  Powder for solution for injection
Treosulfan (Non-proprietary) On Formulary
  tretinoin On Formulary
  Capsule
Tretinoin (Non-proprietary) On Formulary
  trifluridine with tipiracil Restricted NICE TA405
NICE TA669
  Tablet
Lonsurf (Servier Laboratories Ltd) Restricted
  vinblastine sulfate On Formulary
  Solution for injection
Vinblastine sulfate (Non-proprietary) On Formulary
  vincristine sulfate On Formulary
  Solution for injection
Vincristine sulfate (Non-proprietary) On Formulary
  vinorelbine Restricted
  Capsule
Navelbine (Pierre Fabre Ltd) Restricted
  Solution for infusion
Vinorelbine (Non-proprietary) Restricted
Malignant disease / Cytotoxic drug-induced side effects
  folinic acid On Formulary NICE TA212
  Tablet
Folinic acid (Non-proprietary) On Formulary
  Solution for injection
Folinic acid (Non-proprietary) On Formulary
  mesna On Formulary
  Tablet
Mesna (Non-proprietary) On Formulary
  Solution for injection
Mesna (Non-proprietary) On Formulary
Malignant disease / Hyperuricaemia associated with cytotoxic drugs
  allopurinol On Formulary
  Tablet
Allopurinol (Non-proprietary) On Formulary
Malignant disease / Hormone responsive malignancy
  abiraterone acetate Restricted NICE TA259
NICE TA387
NICE TA721
  Tablet
Zytiga (Janssen-Cilag Ltd) Restricted
  apalutamide Restricted NICE TA740
NICE TA741
  Tablet
Erleada (Janssen-Cilag Ltd) Restricted
  bicalutamide On Formulary
  Tablet
Bicalutamide (Non-proprietary) On Formulary
  buserelin On Formulary
  Solution for injection
Suprefact (Neon Healthcare Ltd) On Formulary
  cyproterone acetate On Formulary
  Tablet
Cyproterone acetate (Non-proprietary) On Formulary
  darolutamide Restricted NICE TA660
  Tablet
Nubeqa (Bayer Plc) Restricted
  degarelix Restricted NICE TA404
  Powder and solvent for solution for injection
Firmagon (Ferring Pharmaceuticals Ltd) Restricted
  diethylstilbestrol On Formulary
  Tablet
Diethylstilbestrol (Non-proprietary) On Formulary
  enzalutamide Restricted NICE TA316
NICE TA377
NICE TA580
NICE TA712
  Tablet
Xtandi (Astellas Pharma Ltd) Restricted
  flutamide On Formulary
  Tablet
Flutamide (Non-proprietary) On Formulary
  goserelin On Formulary
  Implant
Zoladex (AstraZeneca UK Ltd) On Formulary
  lanreotide On Formulary
  Solution for injection
Somatuline Autogel (Ipsen Ltd) On Formulary
  medroxyprogesterone acetate On Formulary
  Tablet
Provera (Pfizer Ltd) On Formulary
  megestrol acetate On Formulary
  Tablet
Megestrol acetate (Non-proprietary) On Formulary
Megace (Bausch & Lomb UK Ltd) On Formulary
  octreotide On Formulary
  Solution for injection
Octreotide (Non-proprietary) On Formulary
Sandostatin (Novartis Pharmaceuticals UK Ltd) On Formulary
  Powder and solvent for suspension for injection
Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) Restricted
Malignant disease / Hormone responsive breast cancer
  anastrozole Restricted
  Tablet
Anastrozole (Non-proprietary) Restricted
Arimidex (AstraZeneca UK Ltd) Restricted
  exemestane Restricted
  Tablet
Exemestane (Non-proprietary) Restricted
  fulvestrant Restricted NICE TA503
  Solution for injection
Fulvestrant (Non-proprietary) Restricted
Faslodex (AstraZeneca UK Ltd) Restricted
  letrozole Restricted
  Tablet
Letrozole (Non-proprietary) Restricted
  tamoxifen On Formulary
  Tablet
Tamoxifen (Non-proprietary) On Formulary
  Oral solution
Tamoxifen (Non-proprietary) On Formulary
Malignant disease / Secondary bone metastases and hypercalcaemia
  calcitonin (salmon) On Formulary
  Solution for injection
Calcitonin (salmon) (Non-proprietary) On Formulary
  denosumab Named Patient Only NICE TA204
NICE TA265
  Solution for injection
Xgeva (Amgen Ltd) Named Patient Only
  ibandronic acid Shared Care NICE TA464
  Tablet
Ibandronic acid (Non-proprietary) Shared Care
Bondronat (Atnahs Pharma UK Ltd) Shared Care
  Solution for injection
Ibandronic acid (Non-proprietary) Shared Care
  Solution for infusion
Ibandronic acid (Non-proprietary) Shared Care
Bondronat (Atnahs Pharma UK Ltd) Shared Care
  pamidronate disodium On Formulary
  Solution for infusion
Pamidronate disodium (Non-proprietary) On Formulary
  sodium clodronate On Formulary
  Tablet
Loron (Esteve Pharmaceuticals Ltd) On Formulary
  zoledronic acid Restricted NICE TA464
  Infusion
Zometa (Novartis Pharmaceuticals UK Ltd) Restricted
  Solution for infusion
Zoledronic acid (Non-proprietary) Restricted
Zometa (Novartis Pharmaceuticals UK Ltd) Restricted